Avalon GloboCare Corp. Banner Image

Avalon GloboCare Corp.

  • Ticker AVCO
    Exchange NASDAQ More
  • Industry --None-- More
  • Sector Real Estate More
Avalon GloboCare Corp. Logo Image
  • 1-10 Employees
  • Based in Freehold, New Jersey
Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clientsMore' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
4.8 / 5.0 (160)

Avalon GloboCare Corp. reports have an aggregate usefulness score of 4.8 based on 160 reviews.

Avalon GloboCare Corp.

Most Recent Annual Report

Avalon GloboCare Corp.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Avalon GloboCare Corp. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!